Drug profile · INN
susoctocog alfa
OBIZUR
susoctocog alfa (OBIZUR) is a coagulation factor viii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — susoctocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
susoctocog alfa (OBIZUR) is a coagulation factor viii exogenous protein.
Key facts
INN susoctocog alfa
Brand OBIZUR
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is susoctocog alfa?
susoctocog alfa (OBIZUR) is a coagulation factor viii exogenous protein.
What is the brand name for susoctocog alfa?
OBIZUR is a marketed brand name for susoctocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.